Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $1.12 billion. The enterprise value is $710.94 million.

Market Cap	1.12B
Enterprise Value	710.94M

Important Dates

The last earnings date was Tuesday, November 5, 2024, after market close.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

SNDX has 85.36 million shares outstanding. The number of shares has increased by 20.69% in one year.

Current Share Class	85.36M
Shares Outstanding	85.36M
Shares Change (YoY)	+20.69%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	98.57%
Float	79.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	67.13
Forward PS	6.16
PB Ratio	3.05
P/TBV Ratio	3.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	44.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.99, with a Debt / Equity ratio of 0.00.

Current Ratio	6.99
Quick Ratio	6.92
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,726.95

Financial Efficiency

Return on equity (ROE) is -81.88% and return on invested capital (ROIC) is -55.13%.

Return on Equity (ROE)	-81.88%
Return on Assets (ROA)	-48.67%
Return on Capital (ROIC)	-55.13%
Revenue Per Employee	$86,957
Profits Per Employee	-$1.61M
Employee Count	184
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.07% in the last 52 weeks. The beta is 0.84, so SNDX's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-36.07%
50-Day Moving Average	17.35
200-Day Moving Average	20.02
Relative Strength Index (RSI)	28.91
Average Volume (20 Days)	2,241,915

Short Selling Information

The latest short interest is 14.40 million, so 16.87% of the outstanding shares have been sold short.

Short Interest	14.40M
Short Previous Month	10.60M
Short % of Shares Out	16.87%
Short % of Float	18.18%
Short Ratio (days to cover)	6.54

Income Statement

In the last 12 months, SNDX had revenue of $16.00 million and -$297.06 million in losses. Loss per share was -$3.62.

Revenue	16.00M
Gross Profit	-48.19M
Operating Income	-321.21M
Pretax Income	-264.08M
Net Income	-297.06M
EBITDA	-321.20M
EBIT	-321.21M
Loss Per Share	-$3.62

Full Income Statement

Balance Sheet

The company has $406.40 million in cash and $854,000 in debt, giving a net cash position of $405.54 million or $4.75 per share.

Cash & Cash Equivalents	406.40M
Total Debt	854,000
Net Cash	405.54M
Net Cash Per Share	$4.75
Equity (Book Value)	366.43M
Book Value Per Share	4.28
Working Capital	355.43M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-258.86M
Capital Expenditures	n/a
Free Cash Flow	-258.86M
FCF Per Share	-$3.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,007.58%
Pretax Margin	-1,856.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.69%
Shareholder Yield	-20.69%
Earnings Yield	-26.61%
FCF Yield	-23.19%

Dividend Details

Analyst Forecast

The average price target for SNDX is $37.64, which is 187.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.64
Price Target Difference	187.77%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNDX has an Altman Z-Score of 11.36 and a Piotroski F-Score of 1.

Altman Z-Score	11.36
Piotroski F-Score	1